Medical knowledge is expanding faster than practitioners can absorb. More than 2.5 million biomedical papers are published each year (National Institutes of Health, 2025), and a 2024 Doximity survey found that 70% of physicians feel overwhelmed by the reading required to stay current. MedINT was created to address this widening gap. Tested with leading clinicians across multiple specialties, the platform is a secure, cloud-based clinical decision support system designed for multidisciplinary settings, including tumor boards.

The platform integrates advanced AI capabilities with transparent, human-centered validation tools that help clinicians verify sources, evaluate study quality, and weigh patient-specific factors in real time. This structure ensures that AI-generated insights support, rather than shortcut, expert clinical reasoning.